Mechanisms of Very Late Bioresorbable Scaffold Thrombosis
- 30 October 2017
- journal article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 70 (19), 2330-2344
- https://doi.org/10.1016/j.jacc.2017.09.014
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Bioresorbable Scaffolds versus Metallic Stents in Routine PCINew England Journal of Medicine, 2017
- Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trialThe Lancet, 2016
- Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trialsThe Lancet, 2015
- Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery DiseaseNew England Journal of Medicine, 2015
- Bioresorbable Vascular Scaffolds Versus Metallic Stents in Patients With Coronary Artery DiseaseJournal of the American College of Cardiology, 2015
- Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction—TROFI II trialEuropean Heart Journal, 2015
- A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB JapanEuropean Heart Journal, 2015
- Comparison of Everolimus- and Biolimus-Eluting Coronary Stents With Everolimus-Eluting Bioresorbable Vascular ScaffoldsJournal of the American College of Cardiology, 2015
- A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trialThe Lancet, 2014
- From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade?European Heart Journal, 2011